Tang Capital Management LLC T Scan Therapeutics, Inc. Transaction History

Tang Capital Management LLC

  • $1.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.49 - $3.33 $347,386 - $776,372
-233,145 Reduced 31.18%
514,655 $797,000
Q2 2022

Aug 15, 2022
BUY
$1.65 - $3.58 $903,870 - $1.96 Million
547,800 Added 273.9%
747,800 $2.35 Million
Q1 2022

May 16, 2022
BUY
$2.8 - $5.4 $560,000 - $1.08 Million
200,000 New
200,000 $560,000

Others Institutions Holding TCRX

# of Institutions
93
Shares Held
42.3M
Call Options Held
0
Put Options Held
0
View Full List

About TScan Therapeutics, Inc.

TCRX Quotes by TradingView
  • Ticker TCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,929,800
  • Market Cap $45.6M
  • Description
  • TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...
More about TCRX
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email